Home » Isis Pharma Touts Mid-Stage Study of Experimental Cholesterol Drug
Isis Pharma Touts Mid-Stage Study of Experimental Cholesterol Drug
Isis Pharmaceuticals said its experimental drug reduced the level of triglycerides, a type of fat in the blood that increases the risk of heart diseases, by up to 64 percent in a mid-stage trial.
Reuters
Reuters
Upcoming Events
-
07May
-
14May
-
30May